Newsroom
Sorted by: Latest
-
Beretta Holding’s Counsel Sends Letter to Ruger Board Following the Rejection of Exemption from Shareholder Rights Plan
LUXEMBOURG--(BUSINESS WIRE)--Beretta Holding S.A. (“Beretta Holding” or “we”), a family-owned group leading the global premium light firearms, optics and ammunition industry and the largest shareholder of Sturm, Ruger & Company, Inc. (“Ruger” or the “Company”), with 9.95% ownership of the Company’s outstanding common stock, today sent a letter to Ruger’s Board of Directors (the “Board”) in response to the Board’s letter, received on March 28, rejecting Beretta Holding’s exemption from the s...
-
Truveris Announces Pharmacy Expert “Center of Excellence”
WILMINGTON, Del.--(BUSINESS WIRE)--Truveris, an independent pharmacy cost containment company, today announced the formal launch of their Center of Excellence, a cross-functional team of pharmacy industry and benefits experts specializing in clinical strategy, PBM contract procurement and oversight, data analytics, and other pharmacy-related areas. The Center of Excellence is designed to strengthen benefits decisions, cost containment strategies, and outcomes for all Truveris partners and clien...
-
Andersen Consulting Strengthens Capabilities with Addition of Lukkap
SAN FRANCISCO--(BUSINESS WIRE)--Andersen Consulting adds collaborating firm Lukkap, a consultancy focused on experience-driven capabilities....
-
Broadcasting from Phenom Studios: Inside the AI Infrastructure, Agents and Deployment Models Redesigning Work Operations and Delivering Results in Weeks
PHILADELPHIA--(BUSINESS WIRE)--HR Innovation Showcase Provides Exclusive Look into Groundbreaking WorkOps Innovations...
-
Breakwall Capital and Vitol Announce the Closing of Valor Mining Credit Partners II
NEW YORK & HOUSTON--(BUSINESS WIRE)--Breakwall Capital LP (“Breakwall”), an independent asset management firm specializing in the energy industry, and Vitol, a leader in energy and commodities, announced today the closing of Valor Mining Credit Partners II, L.P. (“VMP II”). The closing of VMP II follows the full deployment of Breakwall and Vitol’s inaugural mining partnership, Valor Mining Credit Partners, L.P., which deployed approximately $470 million of capital in under six months. VMP II pu...
-
Franklin Templeton Strengthens Global Client Group Leadership with Key Appointments
SAN MATEO, Calif.--(BUSINESS WIRE)--Franklin Templeton, a global investment leader, today announced the appointment of Brett Mossman as Head of U.S. Product and Lyenda Delp as Head of Global Insurance and Institutional Asset Solutions, alongside the elevation of Kim Roy to Chief Operating Officer (COO) of the Global Client Group (GCG). These appointments reflect the firm’s strategy of aligning its Global Client Group around a simpler, more connected model designed to accelerate growth and deepe...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 30.03.2026 SDVI.LN IE000YVOQ2A3 40,361.00 USD 1,055,189.67 26.144 ...
-
SECURITIES CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Ramaco Investors of the Securities Class Action Deadline Tonight March 31, 2026
NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ramaco Resources, Inc. (“Ramaco” or the “Company”) (NASDAQ: METC) and reminds investors of the March 31, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm...
-
Sub-Q Bionics Closes $1.5M Pre-Seed Round to Advance Next-Generation Solution for Lymphedema Care
STILLWATER, Minn. & TEL AVIV, Israel--(BUSINESS WIRE)--Sub-Q Bionics, a medical device company developing next-generation solutions to improve care for patients living with lymphedema, today announced the successful close of its $1.5 million pre-seed funding round. The round includes investment from Mayo Clinic and Yeda, the technology transfer company of the Weizmann Institute of Science, as well as several private investors. The Israel Innovation Authority also provided matching funds. The fu...
-
BostonGene RNA Transcriptome Profiling Reveals New ADC Targets in Advanced Solid Tumors
WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, developer of the leading AI foundation model for tumor and immune biology, announced results from the FEASY study in collaboration with The University of Texas MD Anderson Cancer Center, evaluating the clinical utility of comprehensive transcriptome testing in patients with advanced solid tumors. Findings from the prospective study in Cancer Discovery, “Clinical Utility of Comprehensive Transcriptome Testing in Advanced Solid Tumors”, demonstrated th...